These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 6196398

  • 1. Inhibition of RNA synthesis by deoxyadenosine plus deoxycoformycin in resting lymphocytes.
    Matsumoto SS, Yu J, Yu AL.
    J Immunol; 1983 Dec; 131(6):2762-6. PubMed ID: 6196398
    [Abstract] [Full Text] [Related]

  • 2. The effect of nucleosides and deoxycoformycin on adenosine and deoxyadenosine inhibition of human lymphocyte activation.
    Uberti J, Lightbody JJ, Johnson RM.
    J Immunol; 1979 Jul; 123(1):189-93. PubMed ID: 312874
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of DNA repair by deoxyadenosine in resting human lymphocytes.
    Seto S, Carrera CJ, Wasson DB, Carson DA.
    J Immunol; 1986 Apr 15; 136(8):2839-43. PubMed ID: 2870121
    [Abstract] [Full Text] [Related]

  • 4. Purinogenic immunodeficiency diseases. Differential effects of deoxyadenosine and deoxyguanosine on DNA synthesis in human T lymphoblasts.
    Wilson JM, Mitchell BS, Daddona PE, Kelley WN.
    J Clin Invest; 1979 Nov 15; 64(5):1475-84. PubMed ID: 115901
    [Abstract] [Full Text] [Related]

  • 5. Mechanism of deoxyadenosine and 2-chlorodeoxyadenosine toxicity to nondividing human lymphocytes.
    Seto S, Carrera CJ, Kubota M, Wasson DB, Carson DA.
    J Clin Invest; 1985 Feb 15; 75(2):377-83. PubMed ID: 2579098
    [Abstract] [Full Text] [Related]

  • 6. Effects of 2'-deoxycoformycin on the metabolism of purines and the survival of malignant cells in a patient with T-cell leukemia.
    Yu AL, Bakay B, Kung FH, Nyhan WL.
    Cancer Res; 1981 Jul 15; 41(7):2677-82. PubMed ID: 6972800
    [Abstract] [Full Text] [Related]

  • 7. Mechanism of adenosine triphosphate catabolism induced by deoxyadenosine and by nucleoside analogues in adenosine deaminase-inhibited human erythrocytes.
    Bontemps F, Van den Berghe G.
    Cancer Res; 1989 Sep 15; 49(18):4983-9. PubMed ID: 2788493
    [Abstract] [Full Text] [Related]

  • 8. Enhanced cytotoxicity and inhibition of DNA damage repair in irradiated murine L5178Y lymphoblasts and human chronic lymphocytic leukemia cells treated with 2'-deoxycoformycin and deoxyadenosine in vitro.
    Begleiter A, Pugh L, Israels LG, Johnston JB.
    Cancer Res; 1988 Jul 15; 48(14):3981-6. PubMed ID: 3260129
    [Abstract] [Full Text] [Related]

  • 9. Morphological changes in leukemic lymphoblasts and normal lymphocytes treated with deoxyadenosine plus deoxycoformycin.
    Matsumoto SS, Yu AL, Yu J.
    Cancer Invest; 1985 Jul 15; 3(3):225-33. PubMed ID: 3873981
    [Abstract] [Full Text] [Related]

  • 10. Mechanisms of deoxyadenosine toxicity in human lymphoid cells in vitro: relevance to the therapeutic use of inhibitors of adenosine deaminase.
    Lee N, Russell N, Ganeshaguru K, Jackson BF, Piga A, Prentice HG, Foa R, Hoffbrand AV.
    Br J Haematol; 1984 Jan 15; 56(1):107-19. PubMed ID: 6231047
    [Abstract] [Full Text] [Related]

  • 11. DNA strand breaks induced in human T-lymphocytes by the combination of deoxyadenosine and deoxycoformycin.
    Brox L, Ng A, Pollock E, Belch A.
    Cancer Res; 1984 Mar 15; 44(3):934-7. PubMed ID: 6607110
    [Abstract] [Full Text] [Related]

  • 12. DNA repair in nondividing human lymphocytes: inhibition by deoxyadenosine.
    Cohen A, Thompson E.
    Cancer Res; 1986 Apr 15; 46(4 Pt 1):1585-8. PubMed ID: 3485013
    [Abstract] [Full Text] [Related]

  • 13. Effects of deoxyadenosine on the activation of ADA inhibited T & B cells.
    Webster AD, Ip H, Pereira S.
    Clin Exp Immunol; 1982 Dec 15; 50(3):587-95. PubMed ID: 6299634
    [Abstract] [Full Text] [Related]

  • 14. The effect of deoxyadenosine plus deoxycoformycin on replicative and repair synthesis of DNA in human lymphoblasts and isolated nuclei.
    Matsumoto SS, Yu J, Yu AL.
    J Biol Chem; 1988 May 25; 263(15):7153-8. PubMed ID: 3259231
    [Abstract] [Full Text] [Related]

  • 15. Deoxycoformycin-induced response in chronic lymphocytic leukaemia: deoxyadenosine toxicity in non-replicating lymphocytes.
    Kefford RF, Fox RM.
    Br J Haematol; 1982 Apr 25; 50(4):627-36. PubMed ID: 6978147
    [Abstract] [Full Text] [Related]

  • 16. Deoxyadenosine (AdR) inhibition of newly activated lymphocytes: blockade at the G0-G1 interface.
    Redelman D, Bluestein HG, Cohen AH, Depper JM, Wormsley S.
    J Immunol; 1984 Apr 25; 132(4):2030-8. PubMed ID: 6421932
    [Abstract] [Full Text] [Related]

  • 17. 2'Deoxycoformycin and deoxyadenosine affect IL 2 production and IL 2 receptor expression of human T cells.
    Ruers TJ, Buurman WA, van der Linden CJ.
    J Immunol; 1987 Jan 01; 138(1):116-22. PubMed ID: 3097141
    [Abstract] [Full Text] [Related]

  • 18. Consequences of adenosine deaminase deficiency on thymocyte metabolism.
    Thuillier L, Garreau F, Cartier PH.
    Eur J Immunol; 1981 Oct 01; 11(10):788-94. PubMed ID: 6975717
    [Abstract] [Full Text] [Related]

  • 19. Mechanism of deoxyadenosine-induced catabolism of adenine ribonucleotides in adenosine deaminase-inhibited human T lymphoblastoid cells.
    Bagnara AS, Hershfield MS.
    Proc Natl Acad Sci U S A; 1982 Apr 01; 79(8):2673-7. PubMed ID: 6283540
    [Abstract] [Full Text] [Related]

  • 20. Differential sensitivity of leukemic cells to growth inhibition by deoxyadenosine and deoxycoformycin.
    Tanaka M, Kimura K.
    Tohoku J Exp Med; 1985 Dec 01; 147(4):331-41. PubMed ID: 3879563
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.